<DOC>
	<DOCNO>NCT02470741</DOCNO>
	<brief_summary>PLUM evaluate drug letrozole treatment uterine fibroid . This study randomize , blind , placebo-controlled trial oral letrozole among premenopausal woman symptomatic uterine fibroid . Participants randomly assign 1:1 ratio either oral letrozole 2.5mg/day 6 month ( Group A ) intermittent dose letrozole 2.5mg/day identical placebo capsule ( Group B ) .</brief_summary>
	<brief_title>Pilot Letrozole Uterine Myomas</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>1 . ≥21 year old 2 . Premenopausal ( least one menses last 3 month ) 3 . Symptomatic fibroid ( fibroid visualize ultrasound MRI heavy uterine bleeding , pelvic pressure discomfort , urinary bowel abnormality , dyspareunia ) 4 . Fibroids ≤4 total number Fibroids ≤7 total number fibroid le 4cm ( 40 mm ) 5 . Fibroids ≤7cm maximum diameter , screen imaging , ≤4 fibroids total number ( fibroid define mass radiographic characteristic fibroid &gt; 2cm ) 6 . Up date Pap smear screen surveillance 7 . Endometrial biopsy ( require age &gt; 45 year irregular bleeding ) indicate premalignant malignant cell 8 . Agree use nonhormonal barrier method contraception study period risk pregnancy 9 . Has primary care provider gynecologist 10 . Agrees start new medications/treatments fibroid study 11 . Able give inform consent 1 . Fibroids treat surgery , radiologic procedure , GnRH agonist antagonist last 3 month 2 . Any submucosal fibroid ≥2cm &gt; 50 % uterine cavity ( FIGO Type 0 Type 1 fibroid ) amenable hysteroscopic resection 3 . Use exogenous estrogen and/or progestin last month . ( 3 month longacting depoprovera injection , use last 3 month ) 4 . Pregnant , lactating , plan become pregnant next 6 month 5 . Hematocrit &lt; 27 % visit emergency room hospitalization fibroid symptom last 3 month ( safely randomize placebo ) 6 . History osteopenia osteoporosis 7 . History hyperlipidemia 8 . Current liver kidney disease 9 . Unable unwilling attend 4 study visit 10 . Pelvic image concern gynecologic cancer cancer genitourinary gastrointestinal system 11 . Does primary care provider gynecologist</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>